Table of Contents Author Guidelines Submit a Manuscript
Journal of Ophthalmology
Volume 2014 (2014), Article ID 257286, 5 pages
http://dx.doi.org/10.1155/2014/257286
Clinical Study

Posterior Pole Sparing Laser Photocoagulation Combined with Intravitreal Bevacizumab Injection in Posterior Retinopathy of Prematurity

Department of Ophthalmology, Keimyung University School of Medicine, Dongsan Medical Center, 56 Dalseong-ro, Jung-gu, Daegu 700-712, Republic of Korea

Received 13 October 2014; Accepted 8 December 2014; Published 28 December 2014

Academic Editor: Suphi Taneri

Copyright © 2014 Rebecca Kim and Yu Cheol Kim. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. V. H. Gonzalez, G. P. Giuliari, R. M. Banda, D. A. Guell, and M. Wingard, “Confluent laser photocoagulation for the treatment of retinopathy of prematurity,” Journal of Pediatric Ophthalmology and Strabismus, vol. 47, no. 2, pp. 81–85, 2010. View at Publisher · View at Google Scholar · View at Scopus
  2. W. V. Good, J. T. Flynn, A. J. Flach, G. W. Cibis, E. L. Raab, and G. R. Beauchamp, “Final results of the Early Treatment for Retinopathy of Prematurity (ETROP) randomized trial,” Transactions of the American Ophthalmological Society, vol. 102, pp. 233–250, 2004. View at Google Scholar · View at Scopus
  3. W. V. Good, R. J. Hardy, V. Dobson et al., “Final visual acuity results in the early treatment for retinopathy of prematurity study,” Archives of Ophthalmology, vol. 128, no. 6, pp. 663–671, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. R. J. Hardy, W. V. Good, V. Dobson et al., “Multicenter trial of early treatment for retinopathy of prematurity: study design,” Controlled Clinical Trials, vol. 25, no. 3, pp. 311–325, 2004. View at Google Scholar
  5. J. M. Provis, “Development of the primate retinal vasculature,” Progress in Retinal and Eye Research, vol. 20, no. 6, pp. 799–821, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. U. Spandau, Z. Tomic, U. Ewald, E. Larsson, H. Åkerblom, and G. Holmström, “Time to consider a new treatment protocol for aggressive posterior retinopathy of prematurity?” Acta Ophthalmologica, vol. 91, no. 2, pp. 170–175, 2013. View at Publisher · View at Google Scholar · View at Scopus
  7. International Committee for the Classification of Retinopathy of Prematurity, “The International classification of retinopathy of prematurity revisited,” Archives of ophthalmology, vol. 123, no. 7, pp. 991–999, 2005. View at Google Scholar
  8. K. Campbell, “Intensive oxygen therapy as a possible cause of retrolental fibroplasia; a clinical approach,” Medical Jounal of Australia, vol. 2, no. 2, pp. 48–50, 1951. View at Google Scholar
  9. “Multicenter trial of cryotherapy for retinopathy of prematurity. One-year outcome—structure and function. Cryotherapy for Retinopathy of Prematurity Cooperative Group,” Archives of Ophthalmology, vol. 108, no. 10, pp. 1408–1416, 1990. View at Publisher · View at Google Scholar
  10. A. N. Witmer, G. F. J. M. Vrensen, C. J. F. van Noorden, and R. O. Schlingemann, “Vascular endothelial growth factors and angiogenesis in eye disease,” Progress in Retinal and Eye Research, vol. 22, no. 1, pp. 1–29, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. H. A. Mintz-Hittner and R. R. Kuffel Jr., “Intravitreal injection of bevacizumab (avastin) for treatment of stage 3 retinopathy of prematurity in zone i or posterior zone II,” Retina, vol. 28, no. 6, pp. 831–838, 2008. View at Publisher · View at Google Scholar · View at Scopus
  12. K. Maeshima, N. Utsugi-Sutoh, T. Otani, and S. Kishi, “Progressive enlargement of scattered photocoagulation scars in diabetic retinopathy,” Retina, vol. 24, no. 4, pp. 507–511, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. J. C. Law, F. M. Recchia, D. G. Morrison, S. P. Donahue, and R. L. Estes, “Intravitreal bevacizumab as adjunctive treatment for retinopathy of prematurity,” Journal of AAPOS, vol. 14, no. 1, pp. 6–10, 2010. View at Publisher · View at Google Scholar · View at Scopus
  14. E. J. Chung, J. H. Kim, H. S. Ahn, and H. J. Koh, “Combination of laser photocoagulation and intravitreal bevacizumab (Avastin) for aggressive zone I retinopathy of prematurity,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 245, no. 11, pp. 1727–1730, 2007. View at Publisher · View at Google Scholar · View at Scopus
  15. H. A. Mintz-Hittner, K. A. Kennedy, and A. Z. Chuang, “Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity,” The New England Journal of Medicine, vol. 364, no. 7, pp. 603–615, 2011. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Y. Lee, J. B. Chae, S. J. Yang, Y. H. Yoon, and J.-G. Kim, “Effects of intravitreal bevacizumab and laser in retinopathy of prematurity therapy on the development of peripheral retinal vessels,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 248, no. 9, pp. 1257–1262, 2010. View at Publisher · View at Google Scholar · View at Scopus
  17. A. Travassos, S. Teixeira, P. Ferreira et al., “Intravitreal bevacizumab in aggressive posterior retinopathy of prematurity,” Ophthalmic Surgery Lasers and Imaging, vol. 38, no. 3, pp. 233–237, 2007. View at Google Scholar · View at Scopus
  18. P. M. Beer, S. J. Wong, A. M. Hammad, N. S. Falk, M. R. O'Malley, and S. Khan, “Vitreous levels of unbound bevacizumab and unbound vascular endothelial growth factor in two patients,” Retina, vol. 26, no. 8, pp. 871–876, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. M. X. Repka, E. A. Palmer, and B. Tung, “Involution of retinopathy of prematurity,” Archives of Ophthalmology, vol. 118, no. 5, pp. 645–649, 2000. View at Publisher · View at Google Scholar · View at Scopus
  20. B. A. Darlow, A. L. Ells, C. E. Gilbert, G. A. Gole, and G. E. Quinn, “Are we there yet? Bevacizumab therapy for retinopathy of prematurity,” Archives of Disease in Childhood Fetal and Neonatal Edition, vol. 98, no. 2, pp. F170–F174, 2013. View at Publisher · View at Google Scholar · View at Scopus
  21. S. Raizada, J. Al Kandari, and K. Al Sabti, “Will the BEAT-ROP study results really beat ROP?” Investigative Ophthalmology and Visual Science, vol. 52, no. 12, pp. 9288–9289, 2011. View at Publisher · View at Google Scholar · View at Scopus
  22. J. Hu, M. P. Blair, M. J. Shapiro, S. J. Lichtenstein, J. M. Galasso, and R. Kapur, “Reactivation of retinopathy of prematurity after bevacizumab injection,” Archives of Ophthalmology, vol. 130, no. 8, pp. 1000–1006, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. S. Honda, H. Hirabayashi, Y. Tsukahara, and A. Negi, “Acute contraction of the proliferative membrane after an intravitreal injection of bevacizumab for advanced retinopathy of prematurity,” Graefe's Archive for Clinical and Experimental Ophthalmology, vol. 246, no. 7, pp. 1061–1063, 2008. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Sato, K. Wada, H. Arahori et al., “Serum concentrations of bevacizumab (Avastin) and vascular endothelial growth factor in infants with retinopathy of prematurity,” American Journal of Ophthalmology, vol. 153, no. 2, pp. 327.e1–333.e1, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. D. M. Moshfeghi and A. M. Berrocal, “Editorial: Retinopathy of prematurity in the time of bevacizumab: incorporating the beat-rop results into clinical practice,” Ophthalmology, vol. 118, no. 7, pp. 1227–1228, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. M. E. Hartnett and J. R. McColm, “Fibrovascular organization in the vitreous following laser for ROP: implications for prognosis,” Retina, vol. 26, no. 7, pp. S24–S31, 2006. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Y. Kim, S. J. Kim, Y. S. Chang, and W. S. Park, “Combined intravitreal bevacizumab injection and zone i sparing laser photocoagulation in patients with zone i retinopathy of prematurity,” Retina, vol. 34, no. 1, pp. 77–82, 2014. View at Publisher · View at Google Scholar · View at Scopus
  28. L.-I. Larsson and E. Nuija, “Increased permeability of the blood-aqueous barrier after panretinal photocoagulation for proliferative diabetic retinopathy,” Acta Ophthalmologica Scandinavica, vol. 79, no. 4, pp. 414–416, 2001. View at Publisher · View at Google Scholar · View at Scopus